Implant Sciences Signs Testing Agreements for Quantum Sniffer QS-B220
- Explosives and Narcotics Trace Detector to Be Deployed at Airports and Air Cargo Facilities
"We are pleased with the enthusiastic response the QS-B220 is receiving from the user community. Containing no radioactive materials, Implant Sciences' products screen passengers and cargo without health or environmental risks," stated Implant Sciences CEO, Glenn D. Bolduc.
Special Mission Aircraft Market - Global Forecast to 2020
Todd Silvestri, Vice President of Product Development added, "The QS-B220 has been designed to meet or exceed all TSA requirements. With automatic calibration, high throughput, and low maintenance needs, the system is ideally suited for security screening applications."
Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.
Source : Implant Sciences Corp.